Akari Therapeutics akaritx.com


Public lists: Rare Diseases (230)

Akari, formerly Celsus Therapeutics, is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Akari's lead drug, Coversin is a complement inhibitor that acts on complement component-C5, preventing release of C5a and formation of C5b-9 (also known as the membrane attack complex or MAC).

Akari, formerly Celsus Therapeutics, is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Akari's lead drug, Coversin is a complement inhi...Show all

Company (IPO / Went public)

Phone: 646-350-0702

Fax:

24 West 40th Street
8th Floor
New York, 10018
New York, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Akari Therapeutics $0M May 15, 2013

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Akari Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
New Enterprise AssociatesVenture CapitalMenlo Park, California, United StatesOther Investors
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)